Palopegteriparatide for treating chronic hypoparathyroidism [ID6380]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Teprotumumab for treating thyroid eye disease ID6432Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC